Literature DB >> 6320778

Organization of polyoma virus DNA in mouse tumor cell lines.

S K Arya.   

Abstract

Restriction mapping of polyoma virus DNA in mouse tumor cell lines gave patterns that varied with the cell line examined. These reflected differences in both the organization and the state of integration of virus genomes in the host chromosomes. (The cell lines were derived from tumors induced by polyoma virus in vivo and were propagated continuously in culture.) Two of the cell lines contained multiple copies of tandemly integrated virus genomes as well as free virus DNA molecules. Two other cell lines appeared to contain only integrated virus genomes arranged as tandem repeats. Based on restriction analysis with eleven different endonucleases, the virus DNA in one of the cell lines containing both free and integrated virus genomes was not detectably defective or hypermethylated. This is in contrast to most previously described polyoma virus transformed mouse cells. These virus genomes may, however, contain point mutations or unobserved rearrangements. The second cell line possessing free virus DNA molecules contained both nondefective and defective virus genomes. Most, if not all, defective virus genomes in this line were integrated. The two other cell lines possessing only detectable integrated virus DNA apparently contained only defective virus genomes. The defect in both cases was a small deletion (less than or equal to 0.2 kb) encompassing 0.12 map units on the physical map of polyoma virus DNA, a region coding for the proximal part of the large T antigen. Moreover, in contrast to the cell lines with free and detectably nondefective virus DNA, the virus DNA was extensively methylated in cell lines containing only integrated and defective virus genomes.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6320778     DOI: 10.1007/bf01310812

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  27 in total

1.  Studies of parotid-tumor agent in cultures of leukemic tissues of mice.

Authors:  C J DAWE; L W LAW; T B DUNN
Journal:  J Natl Cancer Inst       Date:  1959-10       Impact factor: 13.506

2.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

3.  Complementation and transformation by temperature-sensitive mutants of polyoma virus.

Authors:  W Eckhart
Journal:  Virology       Date:  1969-05       Impact factor: 3.616

4.  Organization and expression of integrated polyoma virus DNA sequences in transformed rodent cells.

Authors:  L Lania; A Hayday; G Bjursell; D Gandini-Attardi; M Fried
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1980

5.  Loss of polyoma virus infectivity as a result of a single amino acid change in a region of polyoma virus large T-antigen which has extensive amino acid homology with simian virus 40 large T-antigen.

Authors:  A C Hayday; F Chaudry; M Fried
Journal:  J Virol       Date:  1983-02       Impact factor: 5.103

6.  Use of restriction enzymes to study eukaryotic DNA methylation: I. The methylation pattern in ribosomal DNA from Xenopus laevis.

Authors:  A P Bird; E M Southern
Journal:  J Mol Biol       Date:  1978-01-05       Impact factor: 5.469

7.  Coding potential and regulatory signals of the polyoma virus genome.

Authors:  E Soeda; J R Arrand; N Smolar; J E Walsh; B E Griffin
Journal:  Nature       Date:  1980-01-31       Impact factor: 49.962

8.  Methylation of Herpesvirus saimiri DNA in lymphoid tumor cell lines.

Authors:  R C Desrosiers; C Mulder; B Fleckenstein
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

9.  Organization of polyoma virus DNA in mammary tumours of athymic mice.

Authors:  S K Arya
Journal:  J Gen Virol       Date:  1982-12       Impact factor: 3.891

10.  Stability of polyoma DNA sequences and virus-coded proteins during tumor formation.

Authors:  K Chowdhury; M L Meltzer; M A Israel
Journal:  J Virol       Date:  1982-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.